Table 2.
Age category | 20–34 | 35–49 | 50–64 | 65–79 | 80+ |
---|---|---|---|---|---|
N | 8098 | 10,424 | 11,941 | 13,224 | 2565 |
Main modela | 1.10 (0.98–1.23) | 1.15 (1.07–1.24) | 1.11 (1.01–1.22) | 0.96 (0.90–1.01) | 0.90 (0.81–1.00) |
Main model, genotypeda | 1.18 (0.96–1.44) | 1.12 (0.98–1.26) | 0.99 (0.87–1.12) | 0.94 (0.85–1.03) | 0.87 (0.75–1.01) |
Adjusted for | |||||
PGSBMIb | 1.20 (0.98–1.47) | 1.12 (0.99–1.28) | 0.98 (0.86–1.12) | 0.93 (0.84–1.02) | 0.88 (0.75–1.03) |
PGSBMI and PGSADc | 1.14 (0.94–1.40) | 1.13 (0.99–1.29) | 0.98 (0.86–1.13) | 0.94 (0.85–1.04) | 0.88 (0.75–1.03) |
By tertiles of PGSBMId | |||||
Lowest tertile | 1.28 (0.91–1.80) | 1.38 (1.08–1.78) | 1.11 (0.87–1.42) | 0.91 (0.76–1.09) | 1.13 (0.86–1.47) |
Middle tertile | 1.20 (0.85–1.70) | 1.12 (0.89–1.40) | 0.91 (0.72–1.16) | 0.87 (0.73–1.03) | 0.79 (0.60–1.04) |
Highest tertile | 1.11 (0.79–1.56) | 0.98 (0.79–1.20) | 0.96 (0.78–1.19) | 0.97 (0.84–1.13) | 0.70 (0.52–0.94) |
p value interaction | 0.55 | 0.04 | 0.44 | 0.50 | 0.01 |
Co-twin control modela | |||||
All twins | 1.06 (0.75–1.48) | 1.21 (0.97–1.50) | 1.18 (0.94–1.49) | 0.90 (0.77–1.05) | 1.16 (0.82–1.64) |
Dizygotic twins | 1.06 (0.73–1.54) | 1.25 (0.98–1.60) | 1.24 (0.96–1.61) | 0.93 (0.79–1.10) | 1.15 (0.78–1.69) |
Monozygotic twins | 1.03 (0.47–2.27) | 1.07 (0.68–1.68) | 0.98 (0.59–1.63) | 0.76 (0.50–1.15) | 1.19 (0.53–2.65) |
Hazard rate ratios (95% confidence intervals) of dementia in relation to 5 units higher body mass index measured at different age categories in the Swedish Twin Registry sample. All models are adjusted for age, sex, smoking, and education
PGS polygenic score, BMI body mass index, AD Alzheimer’s disease
aDementia = BMI + age + sex + smoking + education
bDementia = BMI + age + sex + smoking + education + PGSBMI
cDementia = BMI + age + sex + smoking + education + PGSBMI + PGSAD
dDementia = BMI + age + sex + smoking + education + PGSBMI + BMI*PGSBMI